capillary electrophoresis
Swift Biosciences, BillionToOne Partner to Commercialize COVID-19 Test
BillionToOne's assay detects SARS-CoV-2 in samples from nasal, nasopharyngeal, and oropharyngeal swabs and has a testing capacity of 1 million tests per day.
DxTerity Diagnostics, Patients Choice Get FDA Emergency Use Authorizations for Coronavirus Tests
The two tests, both of which use RT-PCR technology to detect multiple viral targets, may be performed only by their respective developers.
Asuragen Fragile X Diagnostic Test Gets FDA Authorization
The firm's AmplideX Fragile X Dx and Carrier Screen Kit is intended to help diagnose fragile X syndrome and assess parental risk of having a child with the syndrome.
The assay was shown to have a simpler workflow and was able to detect mosaicism, with only a slight decrease in sensitivity compared to a lab-developed test.
Thermo Fisher Scientific Acquires IntegenX
Thermo Fisher said that IntegenX complements and enhances its existing human identification product portfolio.